Form 8-K · Current report
Monster Beverage 8-K, filed Aug 6, 2026
- Filed
- CIK
- 0000865752
- Accession no.
- 0001104659-26-092046
Summary
Monster Beverage reported 2026 second-quarter net sales of $2.54 billion, up 20.2 percent from a year earlier, and net income of $584.5 million, up 19.6 percent, with net income per diluted share of $0.59. CEO Hilton H. Schlosberg said international operations continued to contribute significantly to growth, with net sales to customers outside the United States rising 34.6 percent to about 46 percent of total net sales.
Key points
- Net sales rose 20.2 percent to $2.54 billion for the quarter ended June 30, 2026, from $2.11 billion a year earlier.
- Net sales to customers outside the United States increased 34.6 percent to $1.16 billion, about 46 percent of total net sales.
- Alcohol Brands segment net sales fell 15.2 percent to $32.2 million.
- Six-month net sales rose 23.3 percent to $4.89 billion, with net income up 23.9 percent to $1.15 billion.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition. On August 6, 2026, Monster Beverage Corporation (the “Company”) issued a press release relating to its financial results for the second quarter ended June 30, 2026, a copy of which is furnished as Exhibit 99.1 hereto. The press release did not include certain financial statements, related footnotes and certain other financial information that will be filed with the Securities and Exchange Commission as part of the Company’s Quarterly Report on Form 10-Q. On August 6, 2026, the Company will conduct a conference call at 2:00 p.m. Pacific Time. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.